Codoxo
PrivateLast Round
Series C
Feb 17, 2026
Total Funding Raised
$99.58M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Codoxo is a healthcare AI company that provides a unified cost containment platform using generative AI to identify and reduce fraud, waste, and abuse for healthcare payers, government agencies, and pharmacy benefit managers.
Sector
Healthcare & Life Sciences
Verticals
Healthcare Analytics, Revenue Cycle, Compliance & Risk, Medical AI
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Codoxo Comparables
Compare Codoxo with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Alivia Analytics | 89% | |
| Alaffia Health | 88% | |
| Healthcare Fraud Shield | 88% |
Codoxo Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Feb 17, 2026 | ||||
| Series C | Dec 17, 2025 | ||||
| Series B | Feb 3, 2022 | ||||
| Series A | Jul 2, 2020 | ||||
| Grant | Aug 15, 2018 | ||||
Seed | Jun 12, 2017 |
Codoxo Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 111 West Capital | Series C, Series B |
| The Wallace H. Coulter Foundation | Grant |
| Brewer Lane Ventures | Series C, Series B, Series A |
| Georgia Research Alliance | Series B, Seed, Series A |
| QED Investors | Series C, Series A, Series B |
| Mosley Ventures | Seed, Series A |
| CVS Health Ventures | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 11, 2026
Launched AI-driven Deepfake Detection tool for fraud prevention.
- Mar 11, 2026
Launched Generative AI-driven Unified Cost Containment Platform for healthcare payers.
Recent news
Latest coverage and updates
- recognized_asSep 2, 2026
Codoxo recognized as winner in the "AI Innovation in Regulatory & Compliance" category at 2026 Fierce AI Innovation Awards on Sep 2nd '26.
- recognized_asSep 2, 2026
Codoxo recognized as winner at 2026 Fierce AI Innovation Awards on Sep 2nd '26.
- attends_eventSep 2, 2026
Codoxo attended event 2026 Fierce AI Innovation Awards on Sep 2nd '26.
- recognized_asSep 2, 2026
Codoxo recognized as Inc. 5000 on Aug 13th '26.
- receives_awardSep 2, 2026
Codoxo receives award Fierce Healthcare Innovation Award at Fierce AI Innovation Awards.
Codoxo Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Codoxo's valuation, stock price, and market status.
Is Codoxo a public or private company?
Codoxo is a private company.
What is the current stock price of Codoxo?
Codoxo is a private company with no public stock price. No recent secondary market data is available.
How much is Codoxo worth (valuation)?
Valuation information for Codoxo is not publicly available.
Can I buy Codoxo stock?
Codoxo shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Codoxo's last funding round?
Codoxo's most recent funding round was Series C on February 17, 2026.
Who are the main investors in Codoxo?
Key investors in Codoxo include Brewer Lane Ventures, Georgia Research Alliance, QED Investors, CVS Health Ventures, TechSquare Labs.
Will Codoxo IPO soon?
No public IPO plans have been announced for Codoxo.
How can I track Codoxo secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Codoxo's secondary market activity and sign up for updates.